Oncology Nursing News
WEBSep 27, 2013 · By Chris Ryan. September 19th 2024. The FDA approved amivantamab-vmjw plus chemotherapy for locally advanced or metastatic non–small cell lung cancer (NSCLC) that harbors EGFR exon 19 deletions or exon 21 L858R substitution mutations whose disease has progressed on or after treatment with an EGFR TKI.
Know Your Ports - Oncology Nursing News
WEBDec 21, 2017 · A port is typically placed on the right side of the patient’s chest and about 3 to 5 fingerbreadths below the clavicle. The insertion scar provides a useful landmark, because the port is usually located 0.5 to 1 inch below the surgical incision. Bringing a patient who has large amounts of breast tissue to a fully upright position, with the ...
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
WEBSep 20, 2023 · Opinion: The Media May Have Oversold AOH1996, City of Hope's Pioneering Cancer Drug. September 20, 2023. By Amanda Brink, DNP, APRN, FNP-BC, AOCNP. Opinion. Article. AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early ...
Nurses Play Integral Role in Newly Issued Colorectal Screening …
WEBJul 3, 2018 · The American Cancer Society (ACS) recently updated its guidelines to lower the age to start colorectal cancer screening to 45. Nurses will play a vital role in implementing this important change. “Nurses play such an integral role in patient care, so they also do a tremendous amount of patient education. So, …
First-Line Amivantamab Plus Lazertinib Receives FDA Approval for …
WEBAug 20, 2024 · The FDA approved first-line amivantamab-vmjw (Rybrevant) plus lazertinib (Lazcluze) to treat adult patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 L858R substitution mutations. 1. The regulatory decision was supported by data from the …
What Makes an Effective Nurse Navigator? - Oncology Nursing …
WEBJan 19, 2022 · Oncology nurse navigators, which are also referred to as “ONNs,” are professional registered nurses with oncology-specific clinical knowledge. Professionals in this role help patients navigate the various steps of their cancer care journey by offering education and resources to help promote informed decision making and access to quality ...
Defining and Quantifying the Oncology Nurse Navigator Role
WEBOct 7, 2021 · Oncology nurse navigators, sometimes referred to as “ONNs” are professional registered nurses with oncology specific clinical knowledge. These individuals assist patients alongside all steps of their cancer care journey, offering education and resources to help promoted informed decision making and access to quality health and psychosocial ...
What Are Professional Boundaries and Why Do They Matter?
WEBOct 4, 2017 · The National Council of State Boards of Nursing defines a boundary crossing as a “brief excursion across professional lines of behavior.”. Your action may be unplanned and honestly intended to meet a patient’s or a caregiver’s need. Consider the following: It seems like a harmless, kind gesture. But questions to ask yourself are: 1.
Six Ways Nurses Can Advocate for Patients - Oncology Nursing …
WEBAug 30, 2018 · Six Ways Nurses Can Advocate for Patients. August 30, 2018. By Alene Nitzky, PhD, RN, OCN. Article. This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best serve …
Low-Dose Tamoxifen Shows Continued Efficacy in Adjuvant …
WEBFeb 17, 2023 · Tamoxifen, at a dose of 5 mg daily (babytam), continued to show a benefit over placebo in reducing the risk of recurrence from invasive breast cancers and ductal carcinoma in situ (DCIS) in women with breast intraepithelial neoplasia in a 10-year follow-up of the TAM-01 trial (NCT01357772). According to investigators, the low risk of death ...